GRMLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as GRMLW
Greenland Mines Ltd
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026
$5.61−0.39 (-6.50%)
Close on Oct 19, 2026
- Market cap
- $709.78M
- P/E (TTM)
- –
- Dividend yield
- –